Pliant Therapeutics (PLRX) Competitors $1.46 +0.02 (+1.39%) Closing price 04:00 PM EasternExtended Trading$1.46 +0.01 (+0.34%) As of 05:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PLRX vs. HRTX, RGNX, VERV, TECX, ORKA, MREO, BNTC, AURA, CYRX, and RNACShould you be buying Pliant Therapeutics stock or one of its competitors? The main competitors of Pliant Therapeutics include Heron Therapeutics (HRTX), REGENXBIO (RGNX), Verve Therapeutics (VERV), Tectonic Therapeutic (TECX), Oruka Therapeutics (ORKA), Mereo BioPharma Group (MREO), Benitec Biopharma (BNTC), Aura Biosciences (AURA), Cryoport (CYRX), and Cartesian Therapeutics (RNAC). These companies are all part of the "pharmaceutical products" industry. Pliant Therapeutics vs. Heron Therapeutics REGENXBIO Verve Therapeutics Tectonic Therapeutic Oruka Therapeutics Mereo BioPharma Group Benitec Biopharma Aura Biosciences Cryoport Cartesian Therapeutics Heron Therapeutics (NASDAQ:HRTX) and Pliant Therapeutics (NASDAQ:PLRX) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, media sentiment, analyst recommendations, profitability, community ranking, institutional ownership and valuation. Does the MarketBeat Community believe in HRTX or PLRX? Heron Therapeutics received 592 more outperform votes than Pliant Therapeutics when rated by MarketBeat users. Likewise, 68.87% of users gave Heron Therapeutics an outperform vote while only 63.87% of users gave Pliant Therapeutics an outperform vote. CompanyUnderperformOutperformHeron TherapeuticsOutperform Votes66868.87% Underperform Votes30231.13% Pliant TherapeuticsOutperform Votes7663.87% Underperform Votes4336.13% Which has preferable earnings & valuation, HRTX or PLRX? Heron Therapeutics has higher revenue and earnings than Pliant Therapeutics. Heron Therapeutics is trading at a lower price-to-earnings ratio than Pliant Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHeron Therapeutics$144.29M1.94-$110.56M-$0.09-20.44Pliant Therapeutics$1.58M55.81-$161.34M-$3.47-0.41 Do analysts recommend HRTX or PLRX? Heron Therapeutics currently has a consensus price target of $5.67, indicating a potential upside of 207.97%. Pliant Therapeutics has a consensus price target of $13.31, indicating a potential upside of 824.48%. Given Pliant Therapeutics' higher possible upside, analysts plainly believe Pliant Therapeutics is more favorable than Heron Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Heron Therapeutics 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Pliant Therapeutics 0 Sell rating(s) 12 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the media prefer HRTX or PLRX? In the previous week, Heron Therapeutics had 3 more articles in the media than Pliant Therapeutics. MarketBeat recorded 4 mentions for Heron Therapeutics and 1 mentions for Pliant Therapeutics. Heron Therapeutics' average media sentiment score of 1.00 beat Pliant Therapeutics' score of 0.89 indicating that Heron Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Heron Therapeutics 2 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Pliant Therapeutics 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk and volatility, HRTX or PLRX? Heron Therapeutics has a beta of 1.39, suggesting that its share price is 39% more volatile than the S&P 500. Comparatively, Pliant Therapeutics has a beta of 1.46, suggesting that its share price is 46% more volatile than the S&P 500. Is HRTX or PLRX more profitable? Pliant Therapeutics has a net margin of 0.00% compared to Heron Therapeutics' net margin of -20.31%. Heron Therapeutics' return on equity of 0.00% beat Pliant Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Heron Therapeutics-20.31% N/A -12.72% Pliant Therapeutics N/A -48.91%-41.09% Do insiders & institutionals believe in HRTX or PLRX? 80.0% of Heron Therapeutics shares are owned by institutional investors. Comparatively, 97.3% of Pliant Therapeutics shares are owned by institutional investors. 5.8% of Heron Therapeutics shares are owned by company insiders. Comparatively, 6.4% of Pliant Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. SummaryHeron Therapeutics beats Pliant Therapeutics on 11 of the 18 factors compared between the two stocks. Remove Ads Get Pliant Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PLRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PLRX vs. The Competition Export to ExcelMetricPliant TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$88.18M$6.27B$5.29B$7.35BDividend YieldN/A3.24%5.11%4.32%P/E Ratio-0.436.6921.6917.68Price / Sales55.81222.71373.8892.91Price / CashN/A65.6738.1534.64Price / Book0.185.776.353.94Net Income-$161.34M$142.01M$3.20B$247.45M7 Day Performance14.74%5.79%3.94%3.17%1 Month Performance-15.29%-15.47%-10.35%-8.53%1 Year Performance-88.80%-10.99%10.24%0.31% Pliant Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PLRXPliant Therapeutics4.1449 of 5 stars$1.46+1.4%$13.31+811.8%-89.1%$89.41M$1.58M-0.4490Gap DownHRTXHeron Therapeutics3.4999 of 5 stars$1.96-6.7%$5.67+189.1%-37.2%$298.57M$144.29M-10.89300Positive NewsRGNXREGENXBIO4.7169 of 5 stars$5.93-5.7%$32.78+452.7%-64.8%$297.01M$83.33M-1.18370Analyst ForecastAnalyst RevisionNews CoveragePositive NewsVERVVerve Therapeutics3.0731 of 5 stars$3.34-7.7%$20.67+518.8%-36.8%$296.58M$32.33M-1.36110Analyst ForecastOptions VolumeNews CoverageHigh Trading VolumeTECXTectonic Therapeutic2.8121 of 5 stars$15.53-0.6%$77.75+400.6%N/A$289.84MN/A-2.64120Short Interest ↑Positive NewsGap UpORKAOruka Therapeutics3.0952 of 5 stars$7.62-2.7%$39.86+423.1%N/A$285.30MN/A-1.22N/AUpcoming EarningsNews CoveragePositive NewsHigh Trading VolumeMREOMereo BioPharma Group1.859 of 5 stars$1.83-8.0%$7.71+321.5%-20.8%$283.92M$1M-30.5040High Trading VolumeBNTCBenitec Biopharma2.2055 of 5 stars$12.02-2.4%$24.43+103.2%+185.6%$281.88M$80,000.00-7.9620Short Interest ↑Gap UpAURAAura Biosciences1.9828 of 5 stars$5.52+1.7%$22.75+312.1%-25.6%$277.24MN/A-3.1950Short Interest ↑CYRXCryoport2.5211 of 5 stars$5.49+2.6%$11.83+115.5%-67.0%$274.01M$228.39M-1.621,020Analyst ForecastGap DownRNACCartesian Therapeutics1.7162 of 5 stars$10.11+1.1%$42.14+316.8%-43.7%$261.92M$38.91M-0.1964 Remove Ads Related Companies and Tools Related Companies HRTX Alternatives RGNX Alternatives VERV Alternatives TECX Alternatives ORKA Alternatives MREO Alternatives BNTC Alternatives AURA Alternatives CYRX Alternatives RNAC Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PLRX) was last updated on 4/17/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pliant Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pliant Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PLRX Stock Free PLRX Stock Alerts